missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CARD11/CARMA1 Antibody (SR1136), Novus Biologicals™
  7. 18626904

CARD11/CARMA1 Antibody (SR1136), Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP3-22214-100ul

 View more versions of this product

Product Code. 18626904

  • 449.00€ / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CARD11/CARMA1 Monoclonal antibody specifically detects CARD11/CARMA1 in Human, Mouse samples. It is validated for Western Blot, Immunofluorescence
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CARD11/CARMA1
Monoclonal
Unconjugated
PBS, pH 7.4, 150mM NaCl, 50% glycerol.
Rabbit
Affinity purified
RUO
Primary
Human, Mouse
Purified
Western Blot, Immunofluorescence
SR1136
Western Blot 1:500-1:2000, Immunocytochemistry/Immunofluorescence 1:50-1:200
BIMP3card-maguk protein 1, CARD-containing MAGUK protein 1, Carma 1, CARMA1bcl10-interacting maguk protein 3, caspase recruitment domain family, member 11, caspase recruitment domain-containing protein 11, MGC133069
A synthesized peptide derived from human CARD11/CARMA1 (Uniprot #: Q9BXL7)
100 μg
Apoptosis
84433
Store at -20° C. Avoid freeze/thaw cycles.
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.